shortagewatch

Home / Companies / Advanz (Amdipharm)

Company family · HQ GB

Advanz (Amdipharm): medicine shortages

private

As of 2 Nov 2026, 81 Advanz (Amdipharm) products have a reported shortage across 11 countries, covering 24 medicines.

Products short81rank #23 of 464
Medicines24active ingredients
Countries11/16
New in 90 days14+8 vs market pace
Typical duration11 monthsmedian so far
Manufacturing41%demand-driven 18%

Where

United States5Canada2Germany14Italy15Spain11Ireland8Austria4Belgium5Norway8Sweden8New Zealand1

Which therapeutic classes

Nervous system32Anti-infectives18Systemic hormones12Cardiovascular system8Cancer and immune system3Sensory organs3Blood3Musculoskeletal system1Genito-urinary system and sex hormones1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Advanz (Amdipharm)Advanz (Amdipharm): Manufacturing problem 23 (31%)31%Advanz (Amdipharm): Increased demand 10 (13%)13%Advanz (Amdipharm): Active ingredient shortage 3 (4%)4%Advanz (Amdipharm): Distribution or logistics 7 (9%)9%Advanz (Amdipharm): Commercial decision or withdrawal 1 (1%)Advanz (Amdipharm): Regulatory or licensing 4 (5%)5%Advanz (Amdipharm): Other 2 (3%)Advanz (Amdipharm): Not stated 25 (33%)33%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

4647474831 Oct2026-10-31: 471 Nov2026-11-01: 472 Nov2026-11-02: 47

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 1Jan ’25: 1Feb: 1FebMar: 0Apr: 3May: 0MayJun: 0Jul: 1Aug: 0AugSep: 0Oct: 0Nov: 5NovDec: 20Jan ’26: 4Feb: 4FebMar: 1Apr: 2May: 2MayJun: 0Jul: 1Aug: 3AugSep: 5Oct: 6Nov: 0Nov

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Advanz (Amdipharm)81

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Advanz (Amdipharm): 81 / 24Advanz (Amdipharm)

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Paliperidone2528 Jun 2024Manufacturing problem11/16
Lanreotide1224 May 2023Manufacturing problem6/16
Erythromycin91 Sep 2022Active ingredient shortage10/16
Phenoxybenzamine31 Dec 2025Not stated1/16
Zonisamide36 Feb 2026Increased demand4/16
Fusidic Acid222 Nov 2023Not stated2/16
Gentamicin21 Oct 2026Manufacturing problem3/16
Imipramine26 Feb 2025Not stated5/16
Nilutamide21 Dec 2025Not stated2/16
Roxithromycin231 Aug 2026Regulatory or licensing3/16
Tirofiban215 Apr 2026Manufacturing problem1/16
Alprostadil14 Feb 2026Increased demand2/16
Cefepime and Beta-Lactamase Inhibitor17 Aug 2026Distribution or logistics1/16
Cefixime110 Oct 2026Regulatory or licensing5/16
Ceftobiprole Medocaril130 Sep 2026Other1/16
Flumetasone and Antiinfectives11 Sep 2026Not stated1/16
Flurbiprofen11 Apr 2026Commercial decision or withdrawal1/16
Fusidic Acid16 Nov 2023Manufacturing problem1/16
Golimumab11 Dec 2026Increased demand5/16
Nitrofurantoin125 Sep 2026Manufacturing problem5/16
Sumatriptan120 Oct 2026Not stated13/16
Terazosin115 May 2018Manufacturing problem4/16
Tranexamic Acid19 Sep 2026Not stated10/16
Trifluoperazine131 Oct 2026Manufacturing problem2/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.